Background Smokeless tobacco (SLT) use in Bangladesh is one of the highest in the world. Despite having a tobacco control programme, the use of SLTs has increased in recent years. The objective of this paper is to report on the prevalence of SLTs and challenges faced during control measures in Bangladesh. Methods A wide range of published reports on tobacco in general and SLT were reviewed. Websites of relevant organizations and national survey reports including PubMed were visited to identify national‐ or subnational‐level data. Legislations, policies and their implementation and programmes are reviewed. Additional data were captured by active surveys on SLT products, especially on graphic health warning. The authors’ perspectives on SLT control in Bangladesh were captured through a series of brainstorming sessions. Findings The reported prevalence of SLTs ranged from 21% to 26% among adults. SLT control measures are not adequately addressed despite the existence of several policies and programmes. It is based to the definition of Tobacco Control ACT in 2013. We propose inadequate prioritization and weak policy directives; unregulated industry leading to high production, marketing, violation of package warning and tax evasion; high level of cultural acceptance; and poor awareness of the people as challenges to the control efforts. In addition, a lenient attitude of the government towards the so‐called “cottage” industry made SLTs unabated. We propose prioritization of SLT control, strengthening industry monitoring and tax measures, countering cultural acceptability and public ignorance and cessation support engaging government and civil society organizations as the way forward. Conclusion The control measures should be evidence‐based warranting operational research. Government and non‐government organizations’ collaborative efforts on an immediate, short‐and long‐term basis are recommended to meet the challenges of SLTs. These primarily include policy support for prioritization, enforcement of legislation, industry and marketing regulation, stringent tax measures, denormalizing societal acceptability and cessation support.
Articles reporting research may be full length or brief reports. These should report original research findings within the journal's scope. Papers should generally be a maximum of 4000 words in length, excluding tables, references, abstract and key points of the article, whilst references should not exceed 36. Review PapersComprehensive, authoritative, reviews within the journal's scope. Review articles provide a review of the literature. There are two types of review papers:-systematic review papers: respond to a specific research question, accrue from criterion-based selection of sources, include a quantitative synthesis that includes a statistical method (meta-analysis) and should adhere to PRISMA guidelines. Guidelines used for abstracting data and assessing data quality and validity should be noted in methods section. -narrative reviews: the research question may be broad, and the scope of this review is to discuss a specific topic and keep the readers up-to-date about it. This type of review does not necessarily include a methodological approach and its synthesis is usually qualitative. Narrative reviews should include a "developments" section, with details regarding data sources used, keywords applied, time restrictions and study types selected. All review papers should be generally less than 6000 words, excluding abstract, tables, figures and references. References should not exceed 50 unless on a topic that has an extensive evidence base. The conclusion of the reviews must be specific and stem from the findings. Short ReportsBrief reports of data from original research. Short reports are shorter versions of original articles, may include one table or figure, should not exceed 1500 words and 15 references. Short reports are suitable for the presentation of research that extends previously published research, including the reporting of additional evidence and confirmatory results in other settings, as well as negative results. Authors must clearly acknowledge any work upon which they are building, both published and unpublished. Study ProtocolsArticles describing a research protocol of a study. This article type can be for proposed or for ongoing research and should contain the background, research hypothesis, rationale a detailed methodology of the study. The SPIRIT 2013 Checklist guidelines ideally should be applied. Study protocols submitted for publication must have received ethics approval. Protocols of randomized trials should follow the CONSORT guidelines and must have a trial registration number, while observational studies should follow STROBE guidelines. Methodology PapersPapers that present different methodological approaches that can be used to investigate problems in a relevant scientific field and to encourage innovation. It is suggested that case studies or practical examples, which can be existing ones, are included to demonstrate the consistency and applicability of the methodology. Methodology papers should be generally less than 6000 words, excluding abstract, tables, figures and referen...
Book www.wctoh.orgDisclaimer: This supplement has been created within the context of a memorandum of understanding between "EUEP European Publishing" and "The Union". Responsibility for the scientific content of the supplement is allocated to the Scientific Committee of the WCTOH. All authors are responsible for the content of their abstracts and retain copyright of their abstract under an Open Access, Creative Commons License (CC-BY-4.0). Each abstract is citable and identifiable through its individual Digital Object Identifier (DOI).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.